高级搜索

直肠腺癌组织中microRNA差异表达谱分析

张丽静, 赵增仁, 张志勇, 贺新奇, 樊智彬, 刘 博, 徐学军

张丽静, 赵增仁, 张志勇, 贺新奇, 樊智彬, 刘 博, 徐学军. 直肠腺癌组织中microRNA差异表达谱分析[J]. 肿瘤防治研究, 2014, 41(06): 602-605. DOI: 10.3971/j.issn.1000-8578.2014.06.020
引用本文: 张丽静, 赵增仁, 张志勇, 贺新奇, 樊智彬, 刘 博, 徐学军. 直肠腺癌组织中microRNA差异表达谱分析[J]. 肿瘤防治研究, 2014, 41(06): 602-605. DOI: 10.3971/j.issn.1000-8578.2014.06.020
ZHANG Lijing, ZHAO Zengren, ZHANG Zhiyong, HE Xinqi, FAN Zhibin, LIU Bo, XUXuejun. Differential Expressions of microRNAs in Rectal Adenocarcinoma Tissues[J]. Cancer Research on Prevention and Treatment, 2014, 41(06): 602-605. DOI: 10.3971/j.issn.1000-8578.2014.06.020
Citation: ZHANG Lijing, ZHAO Zengren, ZHANG Zhiyong, HE Xinqi, FAN Zhibin, LIU Bo, XUXuejun. Differential Expressions of microRNAs in Rectal Adenocarcinoma Tissues[J]. Cancer Research on Prevention and Treatment, 2014, 41(06): 602-605. DOI: 10.3971/j.issn.1000-8578.2014.06.020

直肠腺癌组织中microRNA差异表达谱分析

基金项目: 国家自然科学基金资助项目(81072034);河北省自然科学研究计划资助项目(C2011206103);河北省科技计划资助项目(12396105D)
详细信息
    作者简介:

    张丽静(1980-),女,硕士,主治医师,主要从事消化道肿瘤的研究

    通讯作者:

    徐学军,E-mail:Xuxuejun85917233@sohu.com

  • 中图分类号: R735.3+7

Differential Expressions of microRNAs in Rectal Adenocarcinoma Tissues

  • 摘要: 目的 研究直肠癌及正常直肠黏膜中微小RNA(miRNA)表达谱差异,寻找并验证具有差异表达的miRNA。方法 提取3例直肠癌患者的癌组织及其对应远端正常直肠黏膜中的miRNA,采用微阵列芯片分析,获得直肠癌 miRNA表达谱。另取 15例直肠癌患者手术切除标本的癌组织及正常黏膜组织,采用实时定量RT-PCR法对其中具有表达差异的 hsa-miR-187*和hsa-miR-224进行进一步验证。结果 共筛选出70个直肠癌相关的差异表达miRNA,其中33个表达上调,37个表达下调。其中肿瘤/正常倍数小于0.5的有22个,肿瘤/正常倍数大于4的有17个。在另外15对验证样本中证实hsamiR-187*在直肠癌中表达下调(P<0.001),hsa-miR-224表达上调(P<0.001)。结论 直肠癌和正常直肠黏膜相比有其特异的miRNA表达谱, miRNA在直肠癌的发生中可能起到重要作用。

     

    Abstract: Objective To compare the expression profiles of microRNAs (miRNAs) between rectal adenocarcinoma and normal rectal mucosal tissues, further to identify the differentially expressed miRNA possibly associated with the development of rectal cancer. Methods miRNA expression profi les of three rectal adenocarcinoma samples and related normal rectal mucosal tissues were performed by miRNA microarray analysis. Real-time quantitative RT-PCR was performed to confirm the expressions of hsamiR-187* and hsa-miR-224 in another 15 cases of rectal adenocarcinoma. Results A total of 70 miRNAs were found to be differentially expressed in rectal adenocarcinoma and normal tissues, including 33 upregulated miRNAs and 37 down-regulated miRNAs. Compared with normal rectal samples, hsa-miR-187* expression was down-regulated in rectal adenocarcinoma(P<0.001), while hsa-miR-224 expression was upregulated (P<0.001). Conclusion Compared with that in normal rectal mucosal tissues, the specifi c miRNA expression profi le might play an important role in the development of rectal adenocarcinoma.

     

  • [1] He X, Dong Y, Wu CW, et al. MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating oncogene BMI-1 polycomb ring finger oncogene[J]. Mol Med, 2013, 18:1491-8.
    [2] Liu YL, Zhao FL, Wang XS. Analysis of clinicopathologic features and prognosis in 2414 patients with rectal cancer[J]. Zhonghua Wei Chang Wai Ke Za Zhi, 2010,13(12): 913-6. [刘彦 龙, 赵发林, 王锡山. 2414例直肠癌患者的临床病理特征及预后 分析[J] 中华胃肠外科,2010,13(12):913-6.]
    [3] Chen X, Guo X, Zhang H, et al. Role of miR-143 targeting KRAS in colorectal tumorigenesis[J]. Oncogene, 2009, 28(10): 1385-92.
    [4] Liu L, Chen L, Xu Y, et al. microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells[J]. Biochem Biophys Res Commun, 2010, 400(2): 236-40.
    [5] Liang L, Li X, Zhang X, et al. microRNA-137, a HMGA1 target, suppresses colorectal cancer cell invasion and metastasis in mice by directly targeting FMNL2[J]. Gastroenterology, 2013,144(3): 62 4-35.e4.
    [6] Chao A, Lin CY, Lee YS, et al. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2[J]. Oncogene,2012, 31(6):764-75.
    [7] Mulrane L, Madden SF, Brennan DJ, et al. miR-187 is an independent prognostic factor in breast cancer and confers increased invasive potential in vitro[J]. Clin Cancer Res, 2012, 18 (24):6702-13.
    [8] Fuse M, Kojima S, Enokida H,et al. Tumor suppressive microRNAs (miR-222 and miR-31) regulate molecular pathways based on microRNA expression signature in prostate cancer[J]. J Hum Genet, 2012, 57(11):691-9.
    [9] Schultz NA, Andersen KK, Roslind A, et al. Prognostic microRNAs in cancer tissue from patients operated for pancreatic cancer--fi ve microRNAs in a prognostic index[J]. World J Surg, 20 12, 36(11):2699-707.
    [10] Liu H, Zhu L, Liu B, et al. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer[J]. Cancer Lett, 2012, 316(2):196-203.
    [11] Ho CY, Bar E, Giannini C,et al. MicroRNA profi ling in pediatric pilocytic astrocytoma reveals biologically relevant targets, including PBX3, NFIB, and METAP2[J]. Neuro Oncol, 2013, 15 (1):69-82.
    [12] Zhang Y,Takahashi S,Tasaka A,et al.Involvement of microRNA-224 in cell proliferation, migration, invasion, and antiapoptosis in hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 20 13, 28(3):565-75.
    [13] Shen SN, Wang LF, Jia YF, et al. Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer[J]. Diagn Pathol,2013,8:69.
    [14] Lu S, Wang S, Geng S, et al. Upregulation of microRNA-224 confers a poor prognosis in glioma patients[J]. Clin Transl Oncol,2013,15(7):569-74.
    [15] Zhou F, Li S, Meng HM,et al. MicroRNA and histopathological characterization of pure mucinous breast carcinoma[J]. Cancer Biol Med,2013,10(1):22-7.
    [16] Mavridis K, Stravodimos K, Scorilas A. Downregulation and prognostic performance of microRNA 224 expression in prostate cancer[J]. Clin Chem, 2013, 59(1):261-9.
    [17] Fu J, Tang W, Du P, et al. Identifying microRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis[J]. BMC Syst Biol,2012,6:68.
    [18] Vega AB, Pericay C, Moya I, et al. microRNA expression profi le in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers[J]. Oncol Rep,2013,30(1):320-6.
    [19] Olaru AV, Yamanaka S, Vazquez C, et al. MicroRNA-224 negatively regulates p21 expression during late neoplastic progression in inflammatory bowel disease[J]. Inflamm Bowel Dis,2013,19(3):471-80.
    [20] Wang Y, Lee AT, Ma JZ, et al. Profi ling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specifi c target[J]. J Biol Chem,2008, 283(19):13205-15.
    [21] Li Q, Wang G, Shan JL, et al. MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion[J]. J Gastroenterol Hepatol,2010, 25(1):164-71.
计量
  • 文章访问数:  1129
  • HTML全文浏览量:  271
  • PDF下载量:  542
  • 被引次数: 0
出版历程
  • 收稿日期:  2013-05-23
  • 修回日期:  2013-10-22
  • 刊出日期:  2014-06-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭